Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Cardiotoxicity × empagliflozin × Clear all

Phase

Status

Recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Heart Failure 1 Cardiotoxicity 1 Breast Neoplasms 1

Interventions

Social Determinants of Health 2 empagliflozin 1 Positron Emission Tomography Computed Tomography 1 Methods 1 Exercise 1 Echocardiography 1 Chemoradiotherapy 1 Carvedilol 1 Cardiography, Impedance 1 Blood Specimen Collection 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06844669 2026-03-03

HER2HEART-US: Prevention of Cardiotoxicity in Breast Cancer Patients Receiving HER2-directed Therapy

Washington University School of Medicine

Phase 2 Active not recruiting

Breast Neoplasms, Heart Failure, Cardiotoxicity

Data powered by HemOnc (CC BY 4.0) Colophon ⚡